|
Market Closed -
Other stock markets
|
Pre-market 01:13:22 | |||
| 259.60 EUR | -0.88% |
|
265.30 | +2.20% |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Charts UCB
Select your edition
All financial news and data tailored to specific country editions
